Anass Abbad

526 total citations
12 papers, 84 citations indexed

About

Anass Abbad is a scholar working on Infectious Diseases, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Anass Abbad has authored 12 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Animal Science and Zoology. Recurrent topics in Anass Abbad's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (5 papers) and Animal Virus Infections Studies (2 papers). Anass Abbad is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (5 papers) and Animal Virus Infections Studies (2 papers). Anass Abbad collaborates with scholars based in United States, Morocco and Austria. Anass Abbad's co-authors include Jalal Nourlil, Fouzia Radouani, Omar Abidi, Hind Dehbi, Helen Y. Chu, Andrea N. Loes, Nicholas Franko, Ariana Ghez Farrell, Rachel Eguia and Jennifer K. Logue and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and The Journal of Infectious Diseases.

In The Last Decade

Anass Abbad

9 papers receiving 84 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anass Abbad United States 5 34 21 15 13 12 12 84
Lars Ystaas Germany 4 10 0.3× 31 1.5× 34 2.3× 20 1.5× 15 1.3× 6 76
Jacob Pfeil United States 7 25 0.7× 40 1.9× 8 0.5× 16 1.2× 11 0.9× 13 117
Dominic Lenz Germany 8 31 0.9× 69 3.3× 36 2.4× 12 0.9× 8 0.7× 19 170
Dai Keino Japan 7 17 0.5× 38 1.8× 15 1.0× 30 2.3× 13 1.1× 35 117
Nicolas Soriano France 7 14 0.4× 33 1.6× 8 0.5× 8 0.6× 14 1.2× 11 126
Elif Yılmaz Güleç Türkiye 7 46 1.4× 55 2.6× 44 2.9× 12 0.9× 4 0.3× 25 150
Rachael N. McVicar United States 5 52 1.5× 46 2.2× 10 0.7× 16 1.2× 3 0.3× 7 124
Guanying Zhang China 7 52 1.5× 76 3.6× 7 0.5× 12 0.9× 3 0.3× 20 167
Tyler J. Ripperger United States 4 35 1.0× 44 2.1× 13 0.9× 8 0.6× 3 0.3× 5 130
Joanna Jarkiewicz‐Tretyn Poland 6 69 2.0× 33 1.6× 12 0.8× 16 1.2× 12 137

Countries citing papers authored by Anass Abbad

Since Specialization
Citations

This map shows the geographic impact of Anass Abbad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anass Abbad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anass Abbad more than expected).

Fields of papers citing papers by Anass Abbad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anass Abbad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anass Abbad. The network helps show where Anass Abbad may publish in the future.

Co-authorship network of co-authors of Anass Abbad

This figure shows the co-authorship network connecting the top 25 collaborators of Anass Abbad. A scholar is included among the top collaborators of Anass Abbad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anass Abbad. Anass Abbad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Abbad, Anass, Brian Monahan, Gagandeep Singh, et al.. (2025). Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination. mBio. 17(1). e0290125–e0290125.
3.
González‐Domínguez, Irene, Stephen McCroskery, Stefan Slamanig, et al.. (2025). Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models. Frontiers in Immunology. 16. 1524477–1524477. 4 indexed citations
4.
Flanagan, Thomas W., et al.. (2024). Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence. International Journal of Molecular Sciences. 26(1). 88–88. 6 indexed citations
5.
Singh, Gagandeep, Anass Abbad, Johnstone Tcheou, et al.. (2023). Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections. The Journal of Infectious Diseases. 228(5). 564–575. 4 indexed citations
6.
Abbad, Anass, et al.. (2023). Computational analysis of structural and functional evaluation of the deleterious missense variants in the human CTLA4 gene. Journal of Biomolecular Structure and Dynamics. 41(23). 14179–14196.
7.
Farrell, Ariana Ghez, Bernadeta Dadonaite, Allison J. Greaney, et al.. (2022). Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2. Viruses. 14(9). 2061–2061. 18 indexed citations
8.
Abbad, Anass, Salsabil Hamdi, Kamal Marhoum El Filali, et al.. (2022). MBL2 gene polymorphisms related to HIV-1 infection susceptibility and treatment response. Human Immunology. 84(2). 80–88. 1 indexed citations
10.
Abbad, Anass, et al.. (2019). Cryopreservation Impacts Cell Functionality of Long Term Expanded Adipose-Derived Stem Cells. Journal of Stem Cell Research & Therapy. 9(1). 11 indexed citations
11.
Abbad, Anass, Ranawaka A. P. M. Perera, Nhu Nguyen Tran Minh, et al.. (2019). Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018. Eurosurveillance. 24(48). 16 indexed citations
12.
Abbad, Anass, et al.. (2018). Genetics of breast cancer in African populations: a literature review. PubMed. 3. e8–e8. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026